Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2012 1
2013 6
2014 1
2015 1
2016 2
2017 1
2018 2
2019 5
2020 6
2021 9
2022 10
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
New Frontiers on ER Stress Modulation: Are TRP Channels the Leading Actors?
Vestuto V, Di Sarno V, Musella S, Di Dona G, Moltedo O, Gomez-Monterrey IM, Bertamino A, Ostacolo C, Campiglia P, Ciaglia T. Vestuto V, et al. Among authors: musella s. Int J Mol Sci. 2022 Dec 22;24(1):185. doi: 10.3390/ijms24010185. Int J Mol Sci. 2022. PMID: 36613628 Free PMC article. Review.
New 1,2,4-Oxadiazole Nortopsentin Derivatives with Cytotoxic Activity.
Cascioferro S, Attanzio A, Di Sarno V, Musella S, Tesoriere L, Cirrincione G, Diana P, Parrino B. Cascioferro S, et al. Among authors: musella s. Mar Drugs. 2019 Jan 8;17(1):35. doi: 10.3390/md17010035. Mar Drugs. 2019. PMID: 30626057 Free PMC article.
Heat shock protein 90 inhibitors as therapeutic agents.
Gomez-Monterrey I, Sala M, Musella S, Campiglia P. Gomez-Monterrey I, et al. Among authors: musella s. Recent Pat Anticancer Drug Discov. 2012 Sep;7(3):313-36. doi: 10.2174/157489212801820066. Recent Pat Anticancer Drug Discov. 2012. PMID: 22338602 Review.
New TRPM8 blockers exert anticancer activity over castration-resistant prostate cancer models.
Di Sarno V, Giovannelli P, Medina-Peris A, Ciaglia T, Di Donato M, Musella S, Lauro G, Vestuto V, Smaldone G, Di Matteo F, Bifulco G, Castoria G, Migliaccio A, Fernandez-Carvajal A, Campiglia P, Gomez-Monterrey I, Ostacolo C, Bertamino A. Di Sarno V, et al. Among authors: musella s. Eur J Med Chem. 2022 Aug 5;238:114435. doi: 10.1016/j.ejmech.2022.114435. Epub 2022 May 12. Eur J Med Chem. 2022. PMID: 35598411
Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2.
Di Micco S, Rahimova R, Sala M, Scala MC, Vivenzio G, Musella S, Andrei G, Remans K, Mammri L, Snoeck R, Bifulco G, Di Matteo F, Vestuto V, Campiglia P, Márquez JA, Fasano A. Di Micco S, et al. Among authors: musella s. Eur J Med Chem. 2022 Dec 15;244:114857. doi: 10.1016/j.ejmech.2022.114857. Epub 2022 Oct 19. Eur J Med Chem. 2022. PMID: 36332548 Free PMC article.
In Silico Identification and In Vitro Evaluation of New ABCG2 Transporter Inhibitors as Potential Anticancer Agents.
Di Micco S, Di Sarno V, Rossi M, Vestuto V, Konno T, Novi S, Tecce MF, Napolitano V, Ciaglia T, Vitale A, Gomez-Monterrey IM, Bifulco G, Bertamino A, Ostacolo C, Blasi P, Fasano A, Campiglia P, Musella S. Di Micco S, et al. Among authors: musella s. Int J Mol Sci. 2022 Dec 31;24(1):725. doi: 10.3390/ijms24010725. Int J Mol Sci. 2022. PMID: 36614168 Free PMC article.
41 results